Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Aug 16, 2024; 12(23): 5299-5303
Published online Aug 16, 2024. doi: 10.12998/wjcc.v12.i23.5299
Published online Aug 16, 2024. doi: 10.12998/wjcc.v12.i23.5299
Essential role of postoperative follow-up in the management of clear cell sarcoma
Zi-Han Zhang, Jin-Tao Guo, Ying Xie, Si-Yu Sun, Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, China
Jin-Tao Guo, Si-Yu Sun, Engineering Research Center of Ministry of Education for Minimally Invasive Gastrointestinal Endoscopic Techniques, Shenyang 110004, Liaoning Province, China
Author contributions: Zhang ZH, Guo JT, Xie Y, Sun SY contributed to this paper; Zhang ZH designed the outline of the manuscript and drafted the article; Guo JT was responsible for the revision of the manuscript; Xie Y contributed to the editing the manuscript; Sun SY was the study supervisor and was responsible for the revision of the manuscript.
Supported by Liaoning Province Applied Basic Research Program Joint Program Project , No. 2022JH2/101500076 ; Shenyang Young and Middle-aged Science and Technology Innovation Talent Support Program , No. RC200438 ; Tree Planting Program of Shengjing Hospital , No. M1595 ; and the Doctoral Start-up Foundation of Liaoning Province , No. 2022-BS-127 .
Conflict-of-interest statement: All the authors report having no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Si-Yu Sun, MD, PhD, Chief Doctor, Director, Professor, Department of Gastroenterology, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Shenyang 110004, Liaoning Province, China. sun-siyu@163.com
Received: April 7, 2024
Revised: May 18, 2024
Accepted: June 4, 2024
Published online: August 16, 2024
Processing time: 89 Days and 2.8 Hours
Revised: May 18, 2024
Accepted: June 4, 2024
Published online: August 16, 2024
Processing time: 89 Days and 2.8 Hours
Core Tip
Core Tip: Clear cell sarcoma (CCS) is a rare subtype of melanocytic soft tissue sarcoma distinguished by its propensity for metastasis and recurrence. Survival rates markedly diminish in patients with advanced CCS compared with those with early-stage disease. The insidious nature of early occult onset and the limited responsiveness of CCS to chemoradiotherapy underscore the critical importance of routine postoperative follow-up for early detection of recurrent cases, which is crucial for enhancing patient prognosis.